Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival

肿瘤微环境:对 T 细胞肿瘤靶向、激活和存活的影响

基本信息

项目摘要

DESCRIPTION (provided by applicant): An abnormal tumor microenvironment can impair T cell function and limit the immune response. Tumor- derived lactate and an acidic microenvironment, as well as tumor/stromal secretion of TGF¿ can independently and synergistically suppress T cell proliferation, cytokine production and cytotoxicity. We propose to alter components of the tumor microenvironment (pHe, lactate and TGF¿) and assess these effects on PSMA chimeric antigen receptor (CAR) specific T cell therapy in two highly aggressive, immunocompetent animal models of prostate cancer with orthotopic, lung and bone tumor growth. Our central theme and hypothesis is that a markedly abnormal tumor microenvironment affects T cell tumor-targeting and survival, as well as T cell activation, proliferation and effector-function, and that these T cell functions can be monitored using novel dual reporter systems. A constitutive-reporter will be used for imaging T cell trafficking, tumor targeting and survival, and inducible-reporter systems will concurrently image and assess T cell function. One inducible reporter will monitor T cell activation mediated through a PSMA- specific CAR; the other will monitor TGF¿-signaling in T cells. The effects of genetically induced abnormalities in the tumor microenvironment (low pHe, high lactate and high TGF¿) on T cell trafficking and function will be assessed using multimodality imaging techniques. The status of the tumor microenvironment will be assessed repeatedly in the same animal using MRIS to measure pHe and lactate, and microPET to assess tumor hypoxia during tumor growth and during adoptive T cell therapy. Additional ex vivo immunohistochemical cell assays will independently assess the tumor microenvironment and confirm T cell status. We also expect that "normalization" of different components of the tumor microenvironment (pHe, lactate and TGF¿) using pharmacological intervention will significantly enhance T cell therapy; therefore, we have included therapeutic sub-aims to test this hypothesis. The relevance and impact of these studies are that: 1) Lactate, pHe, and TGF¿ levels in the tumor microenvironment are frequently abnormal, particularly in more aggressive tumors, and are associated with a reduced immune response. 2) Importantly, there exist specific treatment modalities to "normalize" these components, and they will be investigated. 3) Many of the imaging strategies developed and used in this project (e.g., MRSI to measure pHe and lactate) could be translated to clinical studies, where monitoring T cell trafficking and function can be monitored in patients using human reporter genes and PET imaging, and where adoptive T cell treatment strategies could be more fully evaluated.
描述(由申请人提供):异常的肿瘤微环境可损害T细胞功能并限制免疫应答。肿瘤来源的乳酸盐和酸性微环境,以及肿瘤/基质分泌的TGF β可以独立地和协同地抑制T细胞增殖、细胞因子产生和细胞毒性。我们建议改变肿瘤微环境的组分(pH、乳酸盐和TGF?),并在两种具有原位、肺和骨肿瘤生长的高度侵袭性、免疫活性的前列腺癌动物模型中评估这些对PSMA嵌合抗原受体(CAR)特异性T细胞治疗的影响。我们的中心主题和假设是,一个显着异常的肿瘤微环境影响T细胞肿瘤靶向和生存,以及T细胞活化,增殖和效应功能,这些T细胞功能可以使用新的双报告系统进行监测。组成型报告基因将用于对T细胞运输、肿瘤靶向和存活进行成像,诱导型报告基因系统将同时对T细胞功能进行成像和评估。一个诱导型报告基因将监测通过PSMA特异性CAR介导的T细胞活化;另一个将监测T细胞中的TGF β信号传导。将使用多模态成像技术评估肿瘤微环境中遗传诱导的异常(低pHe、高乳酸盐和高TGF?)对T细胞运输和功能的影响。在同一只动物中,将使用MRI重复评估肿瘤微环境的状态,以测量pHe和乳酸盐,并使用microPET评估肿瘤生长期间和过继性T细胞治疗期间的肿瘤缺氧。额外的离体免疫组织化学细胞测定将独立评估肿瘤微环境并确认T细胞状态。我们还预计,使用药物干预使肿瘤微环境的不同组分(pHe、乳酸盐和TGF β)“正常化”将显著增强T细胞治疗;因此,我们纳入了治疗子目标来测试这一假设。这些研究的相关性和影响是:1)肿瘤微环境中的乳酸盐,pHe和TGF水平经常异常,特别是在更具侵袭性的肿瘤中,并且与免疫反应降低有关。2)重要的是,存在特定的治疗方式来“正常化”这些组件,他们将进行调查。3)本项目中开发和使用的许多成像策略(例如,MRSI测量pHe和乳酸)可以转化为临床研究,其中可以使用人类报告基因和PET成像监测患者中的T细胞运输和功能,并且可以更全面地评估过继性T细胞治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ronald George Blasberg其他文献

Ronald George Blasberg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ronald George Blasberg', 18)}}的其他基金

Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
图像引导 Trp-IDO/TDO-Kyn-AHR 通路抑制结合免疫治疗
  • 批准号:
    10405124
  • 财政年份:
    2021
  • 资助金额:
    $ 50.35万
  • 项目类别:
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
图像引导 Trp-IDO/TDO-Kyn-AHR 通路抑制结合免疫治疗
  • 批准号:
    10220621
  • 财政年份:
    2021
  • 资助金额:
    $ 50.35万
  • 项目类别:
Enhancement of T cell therapy by incorporating adjunct treatment strategies
通过结合辅助治疗策略增强 T 细胞治疗
  • 批准号:
    9903003
  • 财政年份:
    2019
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging tumor and T cell responses to metabolic and immune modulation therapy
成像肿瘤和 T 细胞对代谢和免疫调节治疗的反应
  • 批准号:
    9544475
  • 财政年份:
    2017
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
嵌合抗原受体 (CAR) T 细胞治疗中的免疫调节成像
  • 批准号:
    9307774
  • 财政年份:
    2016
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
嵌合抗原受体 (CAR) T 细胞治疗中的免疫调节成像
  • 批准号:
    9177127
  • 财政年份:
    2016
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging and Targeting Metastatic-Prone Breast Cancer
易转移性乳腺癌的成像和靶向治疗
  • 批准号:
    9008029
  • 财政年份:
    2013
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging and Targeting Metastatic-Prone Breast Cancer
易转移性乳腺癌的成像和靶向治疗
  • 批准号:
    8634079
  • 财政年份:
    2013
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging and Targeting Metastatic-Prone Breast Cancer
易转移性乳腺癌的成像和靶向治疗
  • 批准号:
    8829787
  • 财政年份:
    2013
  • 资助金额:
    $ 50.35万
  • 项目类别:
Imaging and Targeting Metastatic-Prone Breast Cancer
易转移性乳腺癌的成像和靶向治疗
  • 批准号:
    8422419
  • 财政年份:
    2013
  • 资助金额:
    $ 50.35万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 50.35万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了